Showing 4781-4790 of 9149 results for "".
- Online Exclusive: New Practice-changing Research Links ARD to Bacteriahttps://practicaldermatology.com/news/online-exclusive-new-practice-changing-research-links-rad-to-bacteria/2461701/As many as 95% of people undergoing radiation treatment for cancer will develop acute radiation dermatitis (ARD). Little, however, has been known about why this condition occurs, and there are no widely adapted or standardized treatments for preventing severe ARD. New research may chang
- Dr. Suneel Chilukuri Named Hydrinity Accelerated Skin Science’s Chief Medical Advisorhttps://practicaldermatology.com/news/dr-suneel-chilukuri-named-hydrinity-accelerated-skin-sciences-chief-medical-advisor/2461692/Suneel Chilukuri, MD, is Hydrinity Accelerated Skin Science’s new Chief Medical Advisor. In this role, Dr. Chilukuri will chair the Hydrinity Accelerated Skin Science Medical Advisory Board. He will aid product development as well as develop and oversee all clinica
- MRA Announces $6.3 Million in Grants to Advance Melanoma Preventionhttps://practicaldermatology.com/news/mra-announces-63-million-in-grants-to-advance-melanoma-prevention/2461691/The Melanoma Research Alliance (MRA) announced a new $6.3 million commitment to fund melanoma resear
- Opzelura Helps Beat AD Itchhttps://practicaldermatology.com/news/opzelura-helps-beat-ad-itch/2461690/Opzelura (ruxolitinib) cream 1.5% showed substantial and rapid itch reduction in patients with mild-moderate Atopic Dermatitis (AD). These data were featured in a poster presentation at the Revolutionizing Atopic Dermatitis (RAD) Conference, held from April 29-May 1 in Washing
- Lilly's Lebrikizumab Improves AD on Face, Handshttps://practicaldermatology.com/news/lillys-lebrikizumab-improves-ad-on-face-hands/2461689/Up to 73% of atopic dermatitis patients (AD) receiving lebrikizumab showed Improved or cleared skin on face or hands at 16 weeks, a new study shows. Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients 12 y
- Arctiva Eczema Cream Spells Relief for 91% of Patientshttps://practicaldermatology.com/news/study-arctiva-eczema-cream-spells-relief-for-91-of-patients/2461688/Fully 91% of participants reported improvement in eczema irritation using proprietary Arctiva Eczema Cream, a new study shows. Arctiva Eczema Cream features Hydrosurf glycolipid technology—a blend of fermented ingredients with origins from Antarctica. It is combined with 1% C
- Aquavit News: Company Files Investigational New Drug Application for Dermatoxhttps://practicaldermatology.com/news/aquavit-news-company-files-investigational-new-drug-application-for-dermatox/2461687/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- The Melanoma Research Alliance, SPOTMYUV Continue Partnership to Promote Sun Safetyhttps://practicaldermatology.com/news/the-melanoma-research-alliance-spotmyuv-continue-partnership-to-promote-sun-safety/2461685/The Melanoma Research Alliance and SPOTMYUV are renewing their partnership to promote sun safety and effective use of sunscreen. The two organizations will co-develop sun safety and skin cancer prevention materials that empower consumers to protect themselves and those they love from UV
- Cetaphil Teams Up with Makeup Artist Alexx Mayo for Lizzo's Upcoming Tourhttps://practicaldermatology.com/news/cetaphil-teams-up-with-makeup-artist-alexx-mayo-for-lizzos-upcoming-tour/2461684/Cetaphil cleansers and moisturizers will be an integral part of Lizzo’s skin prep and glam during her upcoming "Special" tour courtesy of makeup artist Alexx Mayo. The brand will enlist Alexx Mayo to create social content showcasing how he relies on
- Galderma's Sculptra Now FDA Approved for Cheek Wrinkleshttps://practicaldermatology.com/news/galdermas-sculptra-now-fda-approved-for-cheeks/2461683/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen production in the